MAIA Biotechnology
Cash Flow

Last updated:

Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of MAIA Biotechnology generated cash of -$13,071,016, which is less than the previous year. Cash used in financing activities reached the amount of $9,270,901 last year. Net change in cash is therefore -$3,800,232.

Cash Flow

MAIA Biotechnology, Inc. (AMEX:MAIA): Cash Flow
2019 -1.56M 187.55K 2.22M
2020 -1.84M 0 798.05K
2021 -4.12M 0 14.03M
2022 -11.65M 0 12.47M
2023 -13.07M 0 9.27M

MAIA Cash Flow Statement (2019 โ€“ 2023)

2023 2022 2021 2020 2019
Cash at beginning of period
10.95M10.57M663.45K1.70M1.70M
Operating activities
Net income
-19.77M-15.76M-12.57M-6.95M-6.49M
Adjustments to reconcile net income to cash generated by operating activities:
Depreciation and amortization
00000
Stock-based compensation expense
3.08M2.31M2.72M3.88M4.13M
Deferred income tax benefit 3.08M2.31M2.72M3.88M4.13M
Changes in operating assets and liabilities:
Accounts receivable, net
158.40K-269.39K000
Inventories
0269.39K000
Accounts payable
471.89K211.34K805.51K-2.30K104.82K
Cash generated by operating activities
-13.07M-11.65M-4.12M-1.84M-1.56M
Investing activities
Purchases Of Investments
00000
Investments In Property Plant And Equipment
-40000
Acquisitions Net
0000187.55K
Cash generated by investing activities
0000187.55K
Financing activities
Common Stock Issued
11.41M13.97M5.74M50K2.08M
Payments for dividends
00000
Repurchases of common stock
000-58.21K0
Repayments of term debt
00-367-3.63K35K
Cash used in financing activities
9.27M12.47M14.03M798.05K2.22M
Net Change In Cash
-3.80M376.63K9.91M-1.04M1.71K
Cash at end of period
7.15M10.95M10.57M663.45K1.70M
Data sourceData source